Medicine
Cefazolin 330 mg/mL powder for injection
Cefazolin 330 mg/mL powder for injection is a generic prescription medicine for intramuscular, intravenous use, made by 4 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Cefazolin for Injection, USP Vial Size Packaged NDC No. 500 mg 10 mL Carton of…
Key facts
- Active ingredient (INN)
- Cefazolin
- Brand
- Sold under the generic name
- Strength
- 330 mg/mL
- Dosage form
- Powder for injection
- Route
- Intramuscular, intravenous
- Packs
- 25 vials, 3 mL, 1 vial and 2 more
- Manufacturers
- Hikma PharmaceuticalsA-S Medication SolutionsHenry ScheinMedical Purchasing Solutions
- Origin register
- US FDA, United States
- Storage
- Cefazolin for Injection, USP Vial Size Packaged NDC No. 500 mg 10 mL Carton of 25 vials 0143-9923-90 1 gram 10 mL Carton of 25 vials 0143-9924-90 Also available as Pharmacy Bulk Package, as follows: Cefazolin for Injection, USP Vial Size Packaged NDC No. 10 grams 100 mL Carton of 10 vials 0143-9983-03 20 grams 100 mL Carton of 10 vials 0143-9665-10 As with other cephalosporins, Cefazolin for…
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- J01DB04 Cefazolin
- HS code (indicative)
- 3004.20Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 18 September 2001
- Identifiers
- RxCUI 1665050, 1665052DailyMed set ID 1dc9de56-e259-4546-a1db-23119a8a088e, 8a772acc-726d-40e6-88ee-b6075cbf9b28, 26de1ce9-06a9-486f-b27d-2ac635f018d1 +2NDC 0143-9924, 50090-4256, 0143-9262 +2Application ANDA065047
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 25 vial in 1 carton / 3 mL in 1 vial | 0143-9262-25 | Hikma Pharmaceuticals | 18 September 2001 |
| 3 mL in 1 vial | 0143-9924-90 | Hikma Pharmaceuticals | 18 September 2001 |
| 25 vial in 1 box / 3 mL in 1 vial | 50090-4256-0 | A-S Medication Solutions | 5 April 2019 |
| 1 vial in 1 bag / 3 mL in 1 vial | 0404-9834-99 | Henry Schein | 9 January 2022 |
| 1 vial in 1 bag / 3 mL in 1 vial | 71872-7027-1 | Medical Purchasing Solutions | 28 February 2018 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 4 October 1973 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Cefazolin
Clinical summary
Cefazolin is a cephalosporin antibacterial indicated for treatment of infections caused by susceptible isolates of the designated microorganisms in adult and pediatric patients for whom appropriate dosing with this formulation can be achieved, among other approved uses. MedsAcross supplies Cefazolin for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about CefazolinFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Cefazolin Sodium prescribing information (B. Braun Medical) · U.S. National Library of Medicine, DailyMed
Need Cefazolin 330 mg/mL powder for injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.